Equibles does not estimate personal net worth.
Get an email with a short summary when Galectin Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get GALT alertsMatt Keller has spoken on 1 investor event across 1 company, most recently for Galectin Therapeutics Inc on September 14, 2026. Galectin Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Galectin Therapeutics Inc includes Joel Lewis (CEO and Board Member), Jack W. Callicutt (CFO), Benjamin S. Carson (Board Member) and 7 others.
“Welcome to the next session at the H.C. Wainwright 28th Annual Global Investment Conference. My name is Matt Keller. I'm a VP in the Equity Research Department, and it is now my pleasure to introduce our next presenting company, Galactin Therapeutics.”
Transcript header (unverified)
Biotechnology · Healthcare
